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Introduction
The nucleus is enclosed by a double-membrane structure termed 
the nuclear envelope, which serves as a physical barrier to sepa-
rate nuclear contents from the cytoplasm. Numerous nuclear 
pores exist as large protein complexes across the nuclear enve-
lope, which allow the transport of water-soluble molecules. In-
terphase chromosomes occupy distinct subnuclear territories. 
The interchromatin space is also well organized and harbors 
multiple nuclear bodies that can be visualized as distinct nuclear 
foci at the microscopic level. To date, nuclear bodies that have 
been studied extensively are nucleoli, promyelocytic leukemia 
(PML) bodies, nuclear speckles, Cajal bodies, paraspeckles, and 
Polycomb bodies (Spector, 2006).
Tremendous effort has been made and allowed us to 
understand the distinct functions of several nuclear bodies: 
(a) Nucleoli are sites of ribosomal DNA transcription, preribosomal 
RNA processing, and preribosomal assembly. (b) Nuclear speck-
les may serve as storage and/or modification sites for splicing 
factors and sites for pre-mRNA splicing. In fact, nuclear speck-
les are often in close proximity to many active genes, suggest-
ing that transcription and RNA splicing are coupled in the cell. 
(c) Cajal bodies are involved in the assembly and maturation of 
small nuclear RNPs (snRNPs; Spector, 2006). Recently, telom-
erase RNA and telomerase reverse transcription were also shown 
to localize to Cajal bodies (Zhu et al., 2004; Tomlinson et al., 
2008). (d) PML bodies engage in a multitude of cellular events, 
including apoptosis, DNA repair, and transcription control, by 
sequestering, modifying, and degrading many partner proteins 
(Lallemand-Breitenbach and de Thé, 2010). (e) Paraspeckles 
are involved in nuclear retention of some A-to-I hyperedited 
mRNAs, and such retention is altered upon environmental 
stress, which provides a control mechanism for gene expression 
The nucleus is a unique organelle that contains essen-tial genetic materials in chromosome territories. The interchromatin space is composed of nuclear sub-
compartments, which are defined by several distinctive 
nuclear bodies believed to be factories of DNA or RNA 
processing and sites of transcriptional and/or posttranscrip-
tional regulation. In this paper, we performed a genome-
wide microscopy-based screening for proteins that form 
nuclear foci and characterized their localizations using 
markers of known nuclear bodies. In total, we identified 
325 proteins localized to distinct nuclear bodies, including 
nucleoli (148), promyelocytic leukemia nuclear bodies (38), 
nuclear speckles (27), paraspeckles (24), Cajal bodies 
(17), Sam68 nuclear bodies (5), Polycomb bodies (2), 
and uncharacterized nuclear bodies (64). Functional vali-
dation revealed several proteins potentially involved in 
the assembly of Cajal bodies and paraspeckles. Together, 
these data establish the first atlas of human proteins in 
different nuclear bodies and provide key information for 
research on nuclear bodies.
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Results
Description and validation of the nuclear 
foci screen
To generate a proteome of nuclear subcompartments, we subcloned 
the Human ORFeome v5.1 Library into a Gateway-compatible 
destination vector. Individual plasmid DNA was transfected 
into HeLa cells in a 96-well format followed by immunofluor-
escence staining of the tagged proteins. Fluorescent images were 
captured by an automated fluorescence microscope, subcellular 
localization of each ORF was reviewed with use of MetaXpress 
software (Molecular Devices), and proteins forming nuclear 
foci were selected for further characterization (Fig. 1 A).
To estimate the accuracy of our study, we randomly selected 
36 proteins in the ORFeome library for which the antibodies 
recognizing endogenous proteins are available. By comparing 
the fluorescence intensities in the transfected and untransfected 
cells, we estimated that the mean level of overexpression is 
2.35-fold of that of endogenous protein (Fig. S1). Moreover, 
34/36 proteins displayed subcellular localization identical to 
that of endogenous protein (Fig. S1). These results suggest that 
(Prasanth et al., 2005). (f) Two classes of complexes designated 
as PRC1 and PRC2 (Polycomb repressive complexes 1 and 2) 
have been found in Polycomb bodies, which are believed to col-
laborate to repress gene transcription through epigenetic si-
lencing (Spector, 2006). However, despite the importance of 
these nuclear bodies, their compositions and regulations are still 
largely unknown.
There are previous attempts in identifying mammalian 
proteins localized to nuclear subcompartments (Sutherland et al., 
2001), which also include proteomic analysis of the nucleolus 
(Andersen et al., 2002; Scherl et al., 2002) as well as nuclear 
speckles (Saitoh et al., 2004). However, an ORFeome-scale sys-
tematic approach has yet to be conducted. This is especially im-
portant for the studies of nuclear bodies because these nuclear 
bodies have no membrane and are difficult to isolate using tra-
ditional biochemical methods. In this study, we took advantage 
of the available 15,483 ORFs in the Human ORFeome Library 
and performed whole-genome screening for proteins localized 
to distinct nuclear bodies. This study allowed us to expand the 
inventory of components in various nuclear bodies and to con-
struct the first nuclear body landscape.
Figure 1. Identification and characterization of proteins in various nuclear subcompartments. (A) Overall schematic flow of this protein localization screen. 
(B) Representative images of proteins that show colocalization with various nuclear body markers. Bar, 10 µm. (C) The pie chart shows the distribution of 
proteins in various nuclear subcompartments (148 nucleolar proteins were not included). A total of 325 proteins that formed nuclear foci were identified in 
this screen, including 148 in the nucleolus, 38 in PML bodies, 27 in nuclear speckles, 24 in paraspeckles, 17 in Cajal bodies, 5 in Sam68 nuclear bodies, 
2 in Polycomb bodies, and 64 proteins in uncharacterized nuclear subcompartments (please also see Table S1).
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suggests that our screening complements previous biochemical 
isolation of the nucleolus (Leung et al., 2006; Ahmad et al., 2009) 
and allows us to identify novel nucleolar proteins. For nuclear 
speckles, 29.6% (8/27) proteins on our list overlapped with those 
in the database, whereas 18.5% (5/27) nonoverlapping nuclear 
speckle proteins were reported elsewhere to be a nuclear speckle 
component (Fig. 2 and Table S3). Similarly, 13.2% (5/38) PML 
body proteins we identified are present in other datasets, whereas 
7.9% (3/38) of the remaining PML body proteins were reported 
by others as components of PML bodies (Fig. 2 and Table S3). 
Overall, 40% (134/325) of the proteins on our list are known 
to be present and/or function in various nuclear compartments.
We also experimentally confirmed that four novel compo-
nents in Cajal bodies and six in paraspeckles are, respectively, 
required for the assembly of Cajal bodies and paraspeckles 
(Fig. 2 and Table S3; please also see Fig. 4, Fig. 5, Fig. 6, and 
Fig. 7 for details), which indicate that many nuclear bodies are 
understudied and contain numerous previously unknown com-
ponents. Of note, we also identified 64 proteins with uncharac-
terized nuclear subcompartments. Most of them (46/64) form 
nuclear foci of <2 µM in diameter and have more than three foci 
per cell (Table S4). The functional significance of these nuclear 
foci remains to be determined.
the tagged proteins are only moderately expressed, and most of 
them exhibit proper localization as their endogenous counterparts.
To validate our screening results, we characterized the lo-
calization of these proteins that display nuclear foci by costain-
ing with various nuclear foci or nuclear body markers (Fig. 1 B) 
or based on the distinct nucleolus morphology. In summary, 
we identified a total of 325 proteins in various nuclear bodies, 
which include 148 nucleolar proteins, 38 proteins in PML bodies, 
27 proteins in nuclear speckles, 24 proteins in paraspeckles, 17 pro-
teins in Cajal bodies, 5 proteins in Sam68 nuclear bodies, 2 pro-
teins in Polycomb bodies, and 64 proteins in uncharacterized 
nuclear subcompartments (Fig. 1 C, Table S1, and Table S2). 
We also identified an additional 48 proteins that are targeted to 
nuclear envelope.
Next, we compared our list of nuclear body proteins to 
available datasets of various nuclear bodies. For nucleolar pro-
teins, we took advantage of an available Nucleolar Proteome 
Database (NOPdb; version 3.0). We found that 37.2% (55 out of 
148) nucleolar proteins identified in our screen overlapped with 
those in NOPdb. Interestingly, 29.1% (43/148) nucleolar proteins 
were exclusively identified in our study but not in NOPdb. More 
importantly, these 43 proteins have already been verified by other 
peer-reviewed articles (Fig. 2 and Table S2). This comparison 
Figure 2. Comparison of our study with datasets on nuclear subcompartments. Datasets were created for each nuclear subcompartment based on online 
databases or recent review articles. NOPdb (Ahmad et al., 2009) was used to represent nucleolar proteins. A proteomic analysis of interchromatin granule 
clusters (Saitoh et al., 2004) was used to represent the nuclear speckles dataset. A PML body interactome analysis (Van Damme et al., 2010) was used to 
represent proteins in PML bodies. A list of Cajal body proteins from a recent review paper (Machyna et al., 2013) was used to represent proteins in Cajal 
bodies. A list of paraspeckle proteins from a review (Bond and Fox, 2009) was used to represent proteins in paraspeckles. Venn graphs were used to show 
the extent of overlapping between an available dataset (green) and our study (blue). A group of proteins that are uniquely identified in our study and have 
been reported by others in the literature were presented in dark blue. The other groups of proteins that are confirmed by our shRNA screen to be involved 
in the assembly of Cajal bodies or paraspeckles were presented in yellow. Please also see Table S2 and Table S3.
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Proteomic analysis of nuclear  
foci proteome
We took advantage of tandem affinity purification to isolate 
protein complexes that contain a randomly selected protein 
from the list of each nuclear subcompartment. The rationale is 
that if the selected protein can interact with relevant proteins at 
the same nuclear subcompartment, it would give us a high con-
fidence that this is a genuine player in that subcompartment. 
Moreover, such proteomic analysis may also help us to identify 
additional components in these subcompartments, which could 
be missed in our initial screening because of various reasons 
(e.g., not present in the ORFeome library, mislocalization caused 
by overexpression, or limited binding partners).
Our initial proteomic profiling revealed that the nuclear 
speckle–targeting protein Fam76B interacted with several 
eukaryotic translation initiation factors (Fig. 3 A), which were 
also reported in the proteomic profiling of human spliceosome 
(Makarov et al., 2002; Bessonov et al., 2010; Agafonov et al., 
2011). However, we found that Fam76B could not inter-
act with several pre-mRNA splicing factors, such as SRSF1, 
SRSF3, and Sc-35, in coimmunoprecipitation (IP; co-IP) ex-
periments (Fig. S3 A). Therefore, Fam76B is likely not a spli-
ceosomal component.
Bioinformatics analysis of nuclear  
foci proteome
We conducted a bioinformatics analysis of the nuclear foci pro-
teome (does not include nucleolar proteins) and found that 62% 
(110/177) of these proteins had been categorized as nucleus- 
localized proteins in the Gene Ontology (GO) database (Fig. S2 A 
and Table S1). Many of these proteins acquire the GO functions 
in ENSEMBL as protein binding, DNA binding, RNA bind-
ing, and chromatin binding properties, all of which are highly 
relevant to close proximity of these proteins to nuclei acids 
(Fig. S2 B and Table S1). Our survey of GO processes revealed 
that about one third of the proteins were associated with regula-
tion of the transcription process, whereas the remaining proteins 
were associated with RNA splicing as well as mRNA process-
ing and splicing, indicating that many DNA and RNA process-
ing proteins are enriched in these nuclear bodies (Fig. S2 C 
and Table S1). A literature search further confirmed that 20% 
(11/52) of proteins annotated with DNA/chromatin binding and 
46% (15/33) of proteins annotated with RNA binding were ex-
perimentally validated (Table S1). In addition, top protein motifs 
in each nuclear subcompartment revealed by using the Inter-
ProScan database (see the Bioinformatics analysis section) were 
also presented (Fig. S2 D, Table S5, and Table S6).
Figure 3. Interactome analysis of nuclear foci proteome. (A–E) A random selected protein from each nuclear subcompartment was used as the bait for 
tandem affinity purification and mass spectrometry analysis. The protein–protein interaction networks characterized for Fam76B (nuclear speckles; A), 
ZBTB45 (PML bodies; B), PHC2 (Polycomb bodies; C), KHDRBS3 (Sam68 nuclear bodies; D), or ZNF24 (paraspeckles; E) are presented in the cartoon 
(please also see Table S7).
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Figure 4. Identification of TOE1 function in regulating Cajal body homeostasis. (A) Schematic workflow showing how the function of proteins localized to 
Cajal bodies was studied (please also see Fig. S3, C and D). (B) TOE1 is an integral component of Cajal bodies. The localization of TOE1 in HeLa cells 
was determined by coimmunostaining using anti­TOE1 and anti­coilin (top) or anti­SMN (bottom). Bars, 10 µm. (C) Proteomic analysis of TOE1­containing 
protein complexes. A cartoon (top part) or a list (bottom part) was presented. (D) SFB­tagged NUAK2 (negative control), TOE1, and TCAB1 were ectopi­
cally expressed in HEK293T cells. Pull­down experiments were conducted using streptavidin beads, and immunoblotting was performed with anti­Flag and 
the indicated antibodies. The asterisk indicates a nonspecific band. (E) Association of endogenous TOE1 and coilin was confirmed by co­IP experiments. 
Immunoprecipitation (IP) was conducted using the anti­coilin antibody or normal rabbit IgG. WB, Western blot.
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Figure 5. TOE1 is recruited to Cajal bodies in a coilin-dependent manner. (A) Schematic representation of TOE1 mutants used in this study. ZnF, zinc 
finger domain; DEDD, deadenylation; FL, full length. (B) Mapping coilin­binding domain in TOE1. 293T cells were transfected with constructs encoding 
full­length or mutant TOE1. Pull­down experiments were performed using streptavidin beads and blotted with anti­Flag (for TOE1 mutants), anti­coilin, anti­DKC1, 
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TOE1 is conserved from Caenorhabditis elegans to mam-
mals. Just like tagged TOE1, endogenous TOE1 colocalized with 
Cajal body components coilin and survival of motor neuron 
(SMN; Fig. 4 B). TOE1 copurified with the Cajal body core 
component coilin, all seven members in the Sm core, box H/ACA 
RNPs, box C/D RNPs, U5 snRNP/triangular RNP, U4/6 snRNP/
triangular RNP, proteins catalyzing U4/6 snRNP recycling, 
and several serine-rich proteins that localize to nuclear speckles 
(Fig. 4 C and Fig. S3 E). TOE1 also coimmunoprecipitated with 
coilin, box H/ACA RNP component DKC1, box C/D RNP com-
ponent fibrillarin (FBL), Sm-D1/snRNP-D1 protein, and SMN 
(Fig. 4 D). The affinity of TOE1 to these proteins is comparable 
to that of TCAB1/WRAP53, a coilin-binding protein essen-
tial for Cajal body formation and telomerase trafficking to Cajal 
bodies (Venteicher and Artandi, 2009; Mahmoudi et al., 2010). 
Moreover, endogenous TOE1 associated with endogenous coilin 
(Fig. 4 E). Collectively, these data suggest that TOE1 is an inte-
gral component of Cajal bodies.
TOE1 targets to Cajal bodies in a  
coilin-dependent manner
We constructed a series of internal deletion mutants of TOE1 
(Fig. 5 A) and found that only the fragments (D2 and D5) con-
taining the highly conserved N terminus as well as the middle 
region harboring zinc finger and NLS signals could pull down 
coilin, DKC1, and FBL (Fig. 5 B and Fig. S4 A). The middle re-
gion of TOE1, but not its N terminus, is required for binding to 
SMN (Fig. 5 B). Moreover, we found that although the binding 
of TOE1 to dyskerin or FBL requires coilin, its binding to SMN 
can occur in a coilin-independent manner (Fig. 5 C).
Instead of forming nuclear foci–like wild-type TOE1, TOE1 
mutants (D1 and D3) defective in coilin binding mainly local-
ized to nucleoplasm, whereas D4, lacking zinc finger and NLS, 
showed a diffuse pattern in the cytoplasm (Fig. 5, D and F). 
Moreover, we found that TOE1 failed to localize to nuclear foci 
in the absence of coilin (Fig. 5, E and G). Together, these data 
suggest that the interaction between TOE1 and coilin is required 
for TOE1 localization to Cajal bodies.
TOE1 is required for Cajal body integrity 
and function
We used siRNAs to knock down the endogenous TOE1 level 
to <10%, whereas the coilin protein level did not change 
(Fig. 6 A). However, although coilin usually forms one to four 
foci per nucleus in control cells, the number of coilin foci in-
creased substantially, and Cajal bodies became dispersed in 
The PML body–targeting protein ZBTB45 interacted with 
nucleosome remodeling and deacetylase corepressor complex 
components (Fig. 3 B), which were known to be recruited by on-
cogenic PML–RAR- to suppress target gene repression (Morey 
et al., 2008). Polycomb body–associated PHC2 was found to in-
teract with the Polycomb repressive complex (Fig. 3 C), which is 
relevant to the function of polycomb bodies in transcription regu-
lation. The Sam68 nuclear body–associated protein KHDRBS3 
bound to the core component KHDRBS1/Sam68 of this nuclear 
body, which mediates alternative splicing in response to extra-
cellular signal (Matter et al., 2002). KHDRBS3 also associated 
with several heterogenous nuclear RNPs (Fig. 3 D), which are 
required for mRNA metabolism and relevant to the function 
of sam68 nuclear bodies in mRNA splicing. The paraspeckle-
targeting protein ZNF24 interacted with lots of zinc finger– 
containing proteins (Fig. 3 E), which may bind RNA. The core 
components of paraspeckles, including pspc1, NONO, and p54nrb, 
all contain RNA recognition motifs that are required for their 
localization and function to retain A-to-I hyperedited RNA at 
paraspeckles (Matter et al., 2002). We showed that ZNF24 in-
teracted with core paraspeckle components PSPC1 and PSF in 
co-IP experiments (Fig. S3 B), indicating that ZNF24 may act 
as a peripheral paraspeckle component and only associate with 
core paraspeckle components in a transient or regulated man-
ner, which was difficult to identify using our tandem affinity 
purification–mass spectrometry method. In summary, this pro-
teomic analysis not only validates our screen but also provides 
lists of proteins that could be useful starting points for the ex-
pansion of the protein–protein interaction network in each of 
these nuclear subcompartments.
Functional validation of Cajal body–localized 
proteins reveals the role of TOE1 in Cajal 
body biogenesis
We sought to demonstrate that the proteins in our nuclear foci 
proteome actually play a role in their corresponding nuclear 
bodies in vivo. To this end, we focused on the proteins localized 
to Cajal bodies. Cajal bodies are sites where snRNP biogene-
sis takes place (Kiss, 2004). We first subjected 10 Cajal body 
proteins to proteomic analysis (Fig. 4 A and Fig. S3, C and D). 
Next, seven proteins showing prominent Cajal body signals 
were subjected to shRNA-mediated gene silencing, and coilin 
foci formation was used as a readout for Cajal body biogenesis 
(Fig. 4 A and Fig. S3, C and D). Given that TOE1 interacts with 
several proteins involved in Cajal body function and that its 
gene silencing affects coilin foci formation, it was picked for 
further characterization.
anti­FBL, or anti­SMN antibodies (please also see Fig. S4 A). (C) Coilin binding is a prerequisite for the loading of DKC1 and FBL, but not SMN, into 
TOE1­containing complexes. Constructs encoding TOE1 or a negative control NFYA were transfected into HeLa cells stably expressing control shRNA 
or coilin shRNA. Pull­down experiments were performed using streptavidin beads and blotted with anti­Flag (for negative control NYFA and TOE1), anti­
coilin, anti­DKC1, anti­FBL, or anti­SMN antibodies. Quantitative results showed the ratio (±SD) of the indicated proteins pulled down by TOE1 in coilin 
knockdown cells relative to those in control cells (n = 3 independent experiments). The asterisk indicates a nonspecific band. (D) TOE1 localizes to Cajal 
bodies in a coilin­dependent manner. Indicated mutants of TOE1 were transiently expressed in HeLa cells and then subjected to immunostaining using 
anti­Flag and anti­coilin antibodies. (E) Cajal body localization of TOE1 was abolished in coilin­depleted cells. Localization of TOE1 was detected in HeLa 
cells stably expressing control shRNA (top) or coilin shRNA (bottom) by immunostaining using anti­TOE1 and anti­coilin antibodies. (F) Quantitative results 
showed the percentage of cells (±SD) in which indicated proteins colocalized with coilin (n = 3 independent experiments). (G) Quantitative results showed 
the percentage of cells (±SD) expressing control or coilin shRNA in which TOE1 colocalized with coilin (n = 3 independent experiments). shCTL, control 
shRNA; WB, Western blot. Bars, 10 µm.
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Figure 6. TOE1 is required for maintaining Cajal body integrity and efficient splicing. (A) TOE1 was down regulated in HeLa cells transfected by siRNA 
against TOE1. (B) Knockdown of TOE1 affected the number and homogeneity of coilin foci. A control and two different siRNAs against TOE1 were used to 
knock down endogenous TOE1 expression in HeLa cells. Localization of TOE1 and coilin was detected by immunostaining using anti­TOE1 and anti­coilin. 
To recover the expression of TOE1, a construct encoding an siRNA­resistant form of TOE1 was cotransfected with siTOE1­A. The exogenous protein was 
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Identification of proteins involved in 
paraspeckle formation by shRNA screen
Paraspeckle is a less-characterized nuclear subdomain involved 
in the control of gene expression via retention of RNA in the 
nucleus (Bond and Fox, 2009). We first confirmed the localization 
of newly identified paraspeckle proteins by demonstrating their 
colocalization with paraspeckle marker protein p54nrb (Fig. 7 A) 
as well as with NEAT1 long noncoding RNA (Fig. 7 B), which 
serves as a core structural component for paraspeckle integra-
tion (Chen and Carmichael, 2009; Clemson et al., 2009; Sasaki 
et al., 2009; Sunwoo et al., 2009). Second, we performed an 
shRNA screen to examine whether any of these newly identified 
paraspeckle proteins would be required for paraspeckle integrity, 
which were scored using p54nrb staining or NEAT1 RNA FISH 
(Fig. 7 C). In addition, NEAT1 expression was also analyzed by 
quantitative RT-PCR (qRT-PCR; Fig. 7 C). A protein was only 
considered to be involved in paraspeckle formation if knock-
down of such protein leads to ≥30% loss/gain in the number 
of paraspeckles in the cell, and the phenotype has to be repro-
ducible by at least two independent shRNAs. When compared 
with RBM14 and NONO, two known components in para-
speckles, we found that knockdown of five other components 
(HECTD3, FAM53B, ZNF24, XIAP, and ENOX1) also reduced 
paraspeckle-containing cells, whereas knockdown of another 
novel component, SH2B1, led to increased paraspeckles in the 
cell (Fig. 7, D and F), indicating that these proteins are posi-
tively or negatively involved in paraspeckle formation. Consis-
tently, down-regulation of five out of eight proteins (HECTD3, 
RBM14, ZNF24, NONO, and XIAP) required for paraspeckle 
formation also negatively affect NEAT1 expression (Fig. 7 E).
Paraspeckle proteins are known to accumulate within peri-
nucleolar cap structures when RNA polymerase II transcription 
is inhibited (Bond and Fox, 2009). Interestingly, the 15 para-
speckles components we identified relocalized to NONO/p54nrb- 
containing structures after actinomycin D treatment (Fig. S5 A), 
suggesting that all of these proteins are likely bona fide compo-
nents of paraspeckles.
Discussion
In this study, we used high throughput microscopic screening 
to identify hundreds of proteins that form nuclear bodies and 
therefore put together an atlas of proteins in nuclear domains 
or nuclear bodies, which is the first step to understanding the 
dynamic regulations and functions ongoing at these nuclear 
subcompartments. Nuclear bodies generally represent sites of 
protein enrichment inside the nucleus. These are likely sites of 
protein–DNA or –RNA interactions and may be factories for 
the nucleoplasm in TOE1 knockdown cells (Fig. 6, B and C). 
This phenotype was fully rescued by the expression of exo-
genous TOE1 (Fig. 6, B and C).
Because coilin is essential for the assembly of multiple 
components inside the Cajal bodies, we examined whether other 
Cajal body protein components would be recruited to residual 
Cajal bodies after TOE1 down-regulation. We observed that SMN 
formed cytoplasmic foci instead of nuclear foci (Fig. 6, D and F), 
suggesting that the SMN complex failed to be recruited to Cajal 
bodies in the absence of TOE1. Moreover, the number Sm-D1 
foci, which normally colocalize with coilin, were also reduced 
(Fig. 6, E and F). The absence of Sm-D1 in Cajal bodies could 
also be caused by a failure of Sm proteins to bind to the cyto-
solic SMN complex, which mediates snRNP assembly (Coady 
and Lorson, 2011). We therefore tested and found that TOE1 is 
not required for the association of cytosolic SMN with Sm-D1 
(Fig. S4 B), indicating that TOE1 is not involved in snRNP as-
sembly. Collectively, we speculate that TOE1 is likely to func-
tion in the maintenance of Cajal body integrity and thereby is 
required for the docking of SMN and snRNPs to Cajal bodies.
Because the primary role of Cajal bodies is for snRNP 
maturation and biogenesis, which is needed for efficient RNA 
splicing (Whittom et al., 2008; Strzelecka et al., 2010b), we 
attempted to demonstrate the functional relevance of TOE1, 
especially its potential functions in RNA splicing and cell pro-
liferation. We used an artificial splicing substrate and found 
that efficient splicing requires coilin as previously reported 
(Whittom et al., 2008) and TOE1 (Fig. 6, G and H). Double 
knockdown of TOE1 and coilin did not show any additive de-
fect in splicing (Fig. 6, G and H). Reconstitution of TOE1-
depleted cells with siRNA-resistant wild-type TOE1, but not 
a coilin binding–deficient mutant of TOE1 (TOE1-D3), rescued 
the splicing defect (Fig. 6, G and H). As a control, we introduced 
the splicing reporter into WI-38 primary cells that lack Cajal 
bodies (Fig. S4 C). The splicing efficiency in WI-38 cells was 
lower than that in HeLa cells. Moreover, knockdown of TOE1 in 
WI-38 cells did not alter splicing activity (Fig. 6, G and H). 
Furthermore, we checked the abundance of the spliced mRNA 
for three endogenous genes (DPP8, NOSIP, and DDX20) and 
found that silencing TOE1 or coilin reduced the levels of spliced 
mRNA by 25–70% in HeLa cells but not in WI-38 cells (Fig. S4 D). 
TOE1 knockdown cells grew slower than mock siRNA-treated 
cells (Fig. 6 I), a phenotype that was also observed in cells 
lacking SMN or coilin (Lemm et al., 2006). Introducing wild-
type TOE1, but not a TOE1-D3 mutant, into siTOE1-treated cells 
restored normal cell proliferation (Fig. 6 I). Together, these data 
suggest that TOE1 is important for Cajal body integrity, which 
contributes to its roles in splicing as well as cell proliferation.
detected by the anti­Flag antibody. (C) The bar graph shows the percentage of cells (±SD) containing more than four coilin foci after the indicated treat­
ment. WT, wild type. (D and E) Down­regulation of TOE1 disrupted localization of SMN complex and newly synthesized Sm­D1. Control siRNA (siCTL)– or 
siTOE1-A–treated cells were subjected to coimmunostaining using anti­coilin and anti­SMN antibodies (D) or anti­coilin and anti­Flag (for HA­Flag–tagged 
Sm­D1) antibodies (E). (F) Quantitative results showed the percentage of cells (±SD) in which the indicated proteins colocalized with coilin (n = 3 indepen­
dent experiments). (G) TOE1 is required for efficient splicing. A splicing reporter was introduced into HeLa cells or WI­38 cells with the indicated treatment. 
24 h later, both spliced and unspliced RNAs were amplified from cDNA using the indicated primer sets. (H) The intensity of unspliced and spliced products 
was quantified by Quantity One software. The ratios of spliced to unspliced RNAs (±SD) were normalized by controls and presented as a bar graph for the 
indicated groups (n = 3 independent experiments). (I) TOE1 down­regulation suppresses cell growth. Cells were harvested and counted at day 1–5 after 
siRNA transfection. The cell numbers (±SD) were plotted against the days after siRNA treatment (n = 3 independent experiments). Bars, 10 µm.
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Figure 7. Identify proteins required for paraspeckle formation using shRNA screen. (A and B) Representative images showed colocalization of newly 
identified paraspeckle proteins with paraspeckles marker p54nrb (A) or NEAT1 long noncoding RNA (B). (C–E) Phenotypic screen for proteins affecting 
paraspeckles assembly. (C) A schematic flow for shRNA screen is presented. (D) Bar graph showed the percentage (±SD) of paraspeckles­containing cells 
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identified mainly localize in the nucleolus and therefore likely 
perform major functions in the nucleolus. As a matter of fact, 
many of them, such as NOLC/NOPP140 and NOP56, are known 
to play physiological roles in preribosomal RNA processing in 
the nucleolus (Chen et al., 1999; Hayano et al., 2003; Thiry et al., 
2009). On the contrary, a mass spectrometry–based proteomic 
screen allows the identification of many candidates, only a small 
fraction of which may primarily reside in the nucleolus. For 
example, ≥20 chaperone proteins, 16 cytoskeleton proteins, and 
21 mitochondria proteins were deposited in NOPdb. The func-
tional significance of these proteins in the nucleolus remains to 
be verified. Second, although we validated all of our 148 candi-
dates using a secondary screen, the early studies only experimen-
tally confirmed a small fraction of their putative nucleolar proteins. 
For instance, only 18/271 (7%) nucleolar candidates in one of 
their proteomic experiments were validated by YFP-tagged fusion 
proteins (Andersen et al., 2002). Third, we found that 66/148 
(45%) of the nucleolar proteins we identified were already re-
ported in the literature (Table S2). This data confirms the accu-
racy of our screen. Because only 37% of nucleolar proteins in 
our screen overlapped with those in NOPdb, we believe that the 
proteomic studies and our cell-based study complement each 
other, and both of them provide important information for fur-
ther functional analysis.
An earlier study used the gene trap technology to visual-
ize the localization of fused endogenous proteins and searched 
for proteins that localize to different nuclear subcompartments 
(Sutherland et al., 2001). This study has the advantage of pro-
tein expression under native promoters. However, the through-
put of such a screen is limited (703 clones were analyzed), and 
it is difficult to expand the screen to genome wide. We found 
that the efficiency of our screen (2.1% or 325/15,483) is lower 
but comparable to theirs (4.2% or 29/703). One possible solu-
tion to increase the coverage of our screen is to combine various 
commercially available cDNA libraries, which will allow us to 
screen more full-length cDNAs.
We also compared our study with a recent review paper 
(Machyna et al., 2013), which extensively summarized known 
protein components of Cajal bodies (Fig. 2 and Table S3). There 
are several discrepancies between our inventory and the pub-
lished list. First, we listed some small nucleolar RNP maturation 
factors, such as Nopp140, FBL, NHP2, dyskerin, and Nop56, as 
nucleolar proteins rather than Cajal body components. This is 
because these proteins predominantly localize to the nucleolus 
with only a small fraction localizing to Cajal bodies. We also 
defined SUMO-1 and PIASy in the same way as they mainly lo-
calize in PML nuclear bodies instead of Cajal bodies. None-
theless, both studies agree on major Cajal body components. In 
addition to seven well-known components of Cajal bodies, such 
as Coilin and WRAP53/TCAB1, recovered by our microscopic 
screen, 13 other already characterized Cajal body components 
transcriptional and posttranscriptional controls and/or other 
cellular functions. It is of great interest to identify novel mem-
bers at various nuclear bodies to gain further understanding of 
the dynamic regulation of these nuclear bodies. The advantage 
of our microscopic screen is that it can readily detect nuclear 
body formation using a straightforward, nonbiased strategy, which 
does not depend on the availability of high quality antibodies. 
Moreover, after the discovery of new members at each nuclear 
body, we could take advantage of the powerful tandem affinity 
purification approach to further expand the protein–protein in-
teraction network within each nuclear subcompartment.
Of course, there are also shortcomings of this approach. We 
constructed our ORFeome library based on the existing Human 
ORFeome V5.1 collection, which sometimes contains truncated 
genes. We also did not confirm that every ORF was successfully 
transferred to a destination vector. As a result, our nuclear foci 
proteome may represent a lion’s share, but not all, of the proteome. 
Our quality control experiments indicate that the majority of 
the proteins we tested (34/36) displayed localization identical to 
that of endogenous protein (Fig. S1). This is likely because the 
size of the HA-Flag tag is small (<20 amino acids) and the ex-
pression level of the tagged protein is moderate (2.35-fold of 
that of endogenous protein). As for further improving our screen-
ing, one issue is that the position of epitope tag may influence 
protein localization. We can subclone our library in a vector with 
C-terminal HA-Flag fusion and compare the results with that of 
N-terminal HA-Flag tag fusion proteins used in this study. We 
can also further reduce the expression of exogenous protein using 
retrovirus-based vectors. Of course, knocking in an epitope tag 
at endogenous locus will permit the examination of this gene 
product at a physiological level, but currently, it is challenging 
to generate such huge number of knockin cells.
Concerning the validity and accuracy of our screening, we 
found that one fourth (79/325) of our inventory could be found 
in various datasets. An additional 57 proteins were previously 
reported in the literature (Table S2 [blue region] and Table S3 
[blue region]). Moreover, we experimentally validated that 10 
new proteins (four from Cajal bodies and six from paraspeckles) 
are required for the assembly of their corresponding nuclear sub-
domains. Together, ≤45% (146/325) of proteins on our list have 
been verified either by peer-reviewed articles or in this study.
When compared with NOPdb of the nucleolus, which 
contains 725 human proteins mainly from two high quality pro-
teomics studies (Andersen et al., 2002; Scherl et al., 2002), the 
number of nucleolar proteins identified by our screen (148) ap-
pears to be quite small. However, there are several differences 
between our studies. First, we have different selection criteria. 
We report a protein as a nucleolar protein only when ≥30% of 
the given protein localizes to the nucleolus. This strict criterion 
may significantly reduce the number of nucleolar proteins re-
ported in this study, but it ensures that the nucleolar proteins we 
determined by p54nrb or NEAT1 staining after the indicated shRNA treatment relative to control mock shRNA­treated cells (n = 3 independent experiments). 
(E) Bar graph showed relative NEAT1 expression (±SD) to control mock shRNA­treated cells and normalized to GAPDH (n = 3 independent experiments). 
Dotted lines display the level of control mock shRNA­treated cells for comparison. (F) Representative images showed phenotypes after shRNA transduc­
tion. The localization of paraspeckles foci was detected with the use of anti­p54nrb antibodies (top) or FITC­RNA probes against NEAT1 (bottom). Arrows 
show the paraspeckles foci labeled by anti­p54nrb antibodies (top) or RNA probes against NEAT1 (bottom). CTL, control. Bars, 10 µm.
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concentration of newly synthesized Sm-D1 protein at residual 
coilin foci was also significantly reduced in cells lacking TOE1. 
Failure of retention of snRNPs in Cajal bodies would lead to 
incomplete snRNP maturation, which should result in com-
promised splicing and reduced cell proliferation. Indeed, TOE1-
depleted cells showed reduced splicing and proliferation capacity, 
which phenocopies coilin deficiency. Moreover, the coilin bind-
ing–deficient mutant of TOE1 was not able to rescue the splicing 
activity and cell proliferation in TOE1-depleted cells, suggesting 
that TOE1 acts with coilin to maintain Cajal body integrity and 
function. In addition, TOE1 knockdown does not alter splicing effi-
ciency in Cajal body–deficient cells, suggesting that TOE1 func-
tions in pre-mRNA splicing via its role in maintaining Cajal body 
homeostasis. We speculate that coilin may initiate the nucleation of 
“nascent” Cajal bodies, whereas assembling of several other factors 
such as TOE1 would allow Cajal bodies to “grow up.” Eventu-
ally, such “mature” Cajal bodies can integrate several small Cajal 
body–specific RNPs, SMN, and snRNPs to complete snRNPs’ 
biogenesis, which is important for efficient splicing and cell sur-
vival (Fig. S5 B).
The number of Cajal bodies varies with transcriptional 
and cellular activities, for example, cells have more Cajal bod-
ies to accommodate increasing levels of RNA processing during 
zebrafish embryogenesis (Strzelecka et al., 2010a). Also, Cajal 
bodies frequently increase when cells undergo transformation or 
immortalization (Spector et al., 1992). These findings raise the 
possibility that cells are capable of forming more Cajal bodies 
with increased demand for snRNP production. Only a fraction 
of TOE1 associates with coilin during normal cell proliferation. 
One possibility is that TOE1 only needs to interact with coilin 
transiently to carry out its function. Another nonexclusive ex-
planation is that the TOE1–coilin interaction may be regulated 
and enhanced when the demand for snRNPs increases under 
certain circumstance, which warrants further investigation.
As another part of validation for our screening, we 
evaluated paraspeckle formation and NEAT1 expression using 
shRNAs. We showed that besides the established paraspeckle 
components such as RBM14 and NONO (Bond and Fox, 2009), 
down-regulation of three proteins (HECTD3, ZNF24, and XIAP) 
reduced paraspeckle foci formation as well as NEAT1 expression, 
which implicates that they may regulate paraspeckles through 
controlling NEAT1 stability. However, knockdown of other three 
proteins (SH2B1, FAM5B, and ENOX1) only affected paraspeckle 
formation without altering NEAT1 expression (Fig. 7, D–F). 
The underlying mechanisms of how these proteins regulate para-
speckles warrant further investigation.
In summary, our ORFeome screen offers an alternative 
approach for the identification of proteins involved in various 
biological functions at distinct nuclear bodies or subnuclear 
compartments. Expansion of this screen, together with follow up 
functional analyses, will uncover the roles of these cellular pro-
cesses in different physiological and pathological conditions.
Materials and methods
Construction of ORFeome library and large-scale screening
A total of 15,483 human ORFs (Human ORFeome v5.1) already in 
pDONR223 vectors were first transferred into a Gateway­compatible 
(SMN, TGS1, SART3, FBL, Gar1, Nop10, NHP2, dyskerin, 
Nop56, Nop58, ELL, LSM10, and LSM11) could also be re-
covered by the interactome analysis of Cajal bodies as described 
in our study.
We observed that several proteins (PJA1, CSPP1, ANKRD54, 
FOSL2, FAM53B, ZNF24, CHMP6, and CSPP1) co-occupy para-
speckles and PML nuclear bodies. One possibility is that a frac-
tion of these proteins originally in paraspeckles may become 
SUMOylated and thus retained in PML bodies. Another possi-
bility is that there is a functional interaction between paraspeck-
les and PML bodies, which remains to be elucidated.
The use of the ORFeome library provides an alternative 
approach that has a better chance to identify proteins directly 
involved in a cellular process. In this study, we showed that 
TOE1 plays a critical role in maintaining Cajal body integrity. 
As for the Cajal body, coilin is believed to be the crucial factor 
for de novo assembly of Cajal bodies (Kaiser et al., 2008). Coilin 
could directly recruit spliceosomal Sm protein through protein– 
protein interactions (Xu et al., 2005; Toyota et al., 2010), a prereq-
uisite for snRNP maturation. The interaction between TCAB1/
WRAP53 and coilin was reported to be important for Cajal body 
formation and for targeting the SMN complex to Cajal bodies 
(Mahmoudi et al., 2010). More recently, a new SUMO isopep-
tidase, USPL1, was identified as a novel component of Cajal 
bodies and required for the integrity of Cajal bodies (Schulz 
et al., 2012). Mouse embryonic fibroblast cells lacking the 85% 
C-terminal region of coilin retain residual foci with morpho-
logical features similar to those Cajal bodies. However, these 
foci failed to recruit spliceosomal snRNPs or the SMN complex 
(Tucker et al., 2001). Similarly, only small nucleolar RNP com-
ponents, but not U snRNPs, formed detectable foci in coilin- 
depleted HeLa cells (Lemm et al., 2006). These findings confirm 
the role of coilin to maintain functional Cajal bodies, which is 
important for snRNP biogenesis and maturation.
TOE1 was originally discovered to be a target of the EGR1 
and responsible for maintaining the cellular level of p21, an in-
hibitor of cell proliferation (De Belle et al., 2003). However, in 
this study, we showed that TOE1 localizes in Cajal bodies and 
interacts with coilin and SMN, indicating that TOE1 may regu-
late both coilin and SMN. Indeed, coilin was dispersed into 
numerous heterogenous nuclear foci in TOE1-depleted cells, 
which is reminiscent of depletion of TGS1, SMN, and PHAX—
key players involved in the snRNP biogenesis pathway (Girard 
et al., 2006; Lemm et al., 2006). snRNP biogenesis involves 
assembly of the Sm core complex to small nuclear RNAs in 
cytoplasm. During this process, the SMN complex binds the 
methylated Sm core complex, allowing specific recruitment of 
small nuclear RNAs and then guiding the Sm complex onto the 
Sm binding site on small nuclear RNAs (Coady and Lorson, 
2011). However, our result indicated that TOE1 is not required 
for SMN binding to Sm-D1 (a subunit in the Sm core complex; 
Fig. S4 B), suggesting that snRNP assembly may not require 
TOE1. Nevertheless, in the absence of TOE1, SMN foci resided in 
cytoplasm and failed to be recruited to tiny residual Cajal bodies, 
which indicates that TOE1 may be required for recruiting the 
SMN complex to Cajal bodies. Consistent with defective SMN-
dependent nuclear import of snRNPs (Narayanan et al., 2004), 
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were purchased from Abcam; and the rabbit monoclonal DLC1 antibody 
was obtained from GeneTex, Inc.
Cell culture and transfection
HeLa, HEK293T (ATCC), and WI­38 cells (obtained from J. Kuang, The 
University of Texas MD Anderson Cancer Center, Houston, TX) were 
maintained in DMEM supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin. Plasmid transfection was performed using polyeth­
ylenimine reagent. To generate a stable cell line expressing SFB­tagged 
proteins, HEK293T cells were selected with 2 mg/ml puromycin 24 h after 
transfection. Resistant clones were picked, and expression of the tagged 
proteins was confirmed by Western blotting and immunofluorescence 
microscopy. To assess the effect of coilin or TOE1 depletion on the cell 
growth, cells were harvested and counted by trypan blue exclusion method 
at 1–5 d after siRNA transfection. To study the effect of actinomycin D on 
the localization of paraspeckle proteins, 0.5 µg/ml actinomycin D was 
used to treat HeLa cells for 4 h at 37°C before fixation.
RNAi
siRNA duplexes against TOE1 and Coilin were synthesized (Invitrogen). 
The sequences of siTOE1­A, 5­GGGATAGCATCAAGCCTGAAGAAAC­3; 
siTOE1­B, 5­CCTTACCCTGGAGTTCTGCAACTAT­3; and siCoilin, 5­AGC­
AUUGGAAGAGUCGAGAGAACAA­3 were used. RNAi Negative 
Control (Medium GC Duplex) was also purchased from Invitrogen. The 
siRNA duplexes were delivered into cells by transfection using Oligo­
fectamine (Invitrogen).
shRNAs were used to down­regulate components in Cajal bodies 
and paraspeckles. shRNAs in the pLKO.1 vector were purchased from 
Sigma­Aldrich, and GIPZ shRNA clones (Thermo Fisher Scientific) were 
obtained from the Cell Based Assay Screening Service core facility (Baylor 
College of Medicine). Lentiviral supernatant was generated by transient 
transfection of 293T cells with the helper plasmids pSPAX2 and pMD2G 
and harvested 48 h after transfection. Supernatants were passed through a 
0.45­µm filter used to infect HeLa cells followed by selection with 2 mg/ml 
puromycin for 2–3 d.
The sequences of shRNAs obtained from Sigma­Aldrich were as 
follows: Coilin shRNA­1 (TRCN0000312465), 5­CCGGGCATTGGAAGA­
GTCGAGAGAACTCGAGTTCTCTCGACTCTTCCAATGCTTTTTG­3; SPOPL 
shRNA­1 (TRCN0000141108), 5­CCGGCGACAACTTGGGTGTAAAG­
ATCTCGAGATCTTTACACCCAAGTTGTCGTTTTTTG­3; SPOPL shRNA­4 
(TRCN0000140307), 5­CCGGCAGTTTGGCATTCCACGCAAACT­
CGAGTTTGCGTGGAATGCCAAACTGTTTTTTG­3; MED26 shRNA­2 
(TRCN0000022009), 5­CCGGGCACTTGAGGAAACACGACTTCTCGA­
GAAGTCGTGTTTCCTCAAGTGCTTTTT­3; TCAB1/WRAP53 shRNA­5 
(TRCN0000000312), 5­CCGGGTTCCTGCATCTTGACCAATACTCGAGTA­
TTGGTCAAGATGCAGGAACTTTTT­3; EAF2 shRNA­2 (TRCN0000005293), 
5­CCGGGCTATGACTTCAAACCTGCTTCTCGAGAAGCAGGTTTGAAG­
TCATAGCTTTTT­3; EAF12 shRNA­12 (TRCN0000005291), 5­CCGGG­
CAAATCCTCTACTTCTGATACTCGAGTATCAGAAGTAGAGGATTTGC­
TTTTT­3; TOE1 shRNA­7 (TRCN0000151849), 5­CCGGCCTTATCA­
TTGACACTGATGACTCGAGTCATCAGTGTCAATGATAAGGTTTTTTG­3; 
ZGPAT shRNA­9 (TRCN0000162675), 5­CCGGCCACAAGAAGATGA­
CTGAGTTCTCGAGAACTCAGTCATCTTCTTGTGGTTTTTTG­3; and control 
shRNA, 5­TCTCGCTTGGGCGAGAGTAAG­3. The clone IDs for each 
GIPZ shRNA are as follows: CHMP6 (V2LHS_136493, V3LHS_311202, 
V3LHS_311201, and V3LHS_311200), CPSF6 (V2LHS_149714, V3LHS_
640886, V3LHS_640888, and V3LHS_367240), CYBA (V2LHS_257604, 
V2LHS_84227, V3LHS_358352, and V3LHS_358350), ENOX1 (V2LHS_
174882, V2LHS_220987, V3LHS_392270, and V3LHS_392266), FAM53A 
(V2LHS_259927, V3LHS_330169, and V3LHS_330166), FAM53B (V2LHS_
79311, V3LHS_309627, V3LHS_309631, and V3LHS_309629), GATA1 
(V2LHS_114063, V3LHS_348340, V3LHS_348337, and V3LHS_348339), 
HECTD3 (V2LHS_254879, V2LHS_156785, V2LHS_156788, and V3LHS_ 
302340), KLF4 (V2LHS_28276, V2LHS_28277, V2LHS_28349, and 
V3LHS_376638), LMNB2 (V2LHS_177319, V3LHS_306247, V3LHS_
306250, and V3LHS_306248), NONO (V3LHS_644243, V3LHS_644241, 
V3LHS_644239, and V3LHS_646457), PSPC1 (V2LHS_156677, V3LHS_
638976, V3LHS_638975, and V3LHS_348420), RBM14 (V2LHS_178055, 
V2LHS_275527, V2LHS_178053, and V2LHS_178054), RBM4B (V3LHS_
404299, V3LHS_331471, and V3LHS_404298), SCYL1 (V2LHS_247649, 
V2LHS_57900, V3LHS_638849, and V3LHS_347641), SH2B1 (V2LHS_
96745, V2LHS_270857, V3LHS_307685, and V3LHS_400799), XIAP 
(V2LHS_94577, V2LHS_94576, V2LHS_94574, and V3LHS_302106), 
ZC3H8 (V2LHS_159014 and V2LHS_159011), ZNF24 (V2LHS_232833, 
V2LHS_95031, V3LHS_341312, and V3LHS_341309), ZNF444 (V2LHS_
175080, V3LHS_392796, V3LHS_392797, and V3LHS_392798), SRSF11 
destination vector containing the HA­Flag tag by LR reaction according to 
the manufacturer’s protocol (Invitrogen). The products were transformed 
into DH5­, and the transformants were positively selected with Luria broth 
medium containing 100 µg/ml ampicillin. The plasmid DNAs were purified 
using a high quality 96­plasmid DNA purification kit (PureLink; Invitrogen).
A day before transfection, 6 × 103 HeLa cells were seeded on 96­
well optical bottom plates (Thermo Fisher Scientific). Plasmid transfection 
was performed with the use of Lipofectamine 2000 (Invitrogen). 24 h after 
transfection, cells were subjected to ionizing radiation (IR; 10 Gy) and fixed 
with 3% paraformaldehyde 6 h later. Next, the cells were permeabilized 
with a 0.5% Triton X­100 solution and blocked with 3% BSA. Cells were 
then subjected to incubation with anti­Flag antibodies (1:5,000 dilution) 
for 2 h, after which they were washed extensively with PBS and incubated 
with rhodamine­conjugated secondary antibodies (Jackson ImmunoResearch 
Laboratories, Inc.) at room temperature for 1 h. Nuclei were counterstained 
with DAPI. Finally, cells were subjected to automated imaging with the 
use of ImageXpress Micro (Molecular Devices) equipped with a 20× air 
objective lens (NA 0.75; Nikon) and a megapixel cooled charge­coupled 
device camera (CoolSNAP HQ 1.4; Photometrics). The fluorescence im­
ages were captured and analyzed using MetaXpress software.
After capturing and analyzing all the images, we selected proteins 
forming nuclear foci from those that do not form nuclear foci for further 
characterization. The secondary screen of proteins forming nuclear foci 
was conducted in untreated or IR­treated cells. Because 325 proteins con­
stitutively form nuclear foci in untreated or IR­treated cells, the validation of 
325 proteins with nuclear foci localization was conducted manually using 
various markers of nuclear bodies or distinct nucleolus morphology in un­
treated cells. Considering that subcellular localizations of the various nu­
clear body markers we used are largely distinct from each other, we have 
not assessed colocalization of each gene with all six marker proteins se­
quentially. Instead, we scored a protein as positive for a particular nuclear 
body component in the case of it showing >70% overlapping with any 
marker protein. During the course of the analysis, we were aware that 
some proteins colocalize with both PML and paraspeckles, and therefore, 
we examined whether the identified PML proteins also localize to para­
speckles or vice versa. Eventually, eight proteins were found to localize in 
both nuclear subcompartments.
To estimate the level of overexpression in our experimental setup, 
we randomly selected 36 proteins in the ORFeome library for which the 
antibodies recognizing endogenous proteins are available. We presented 
the estimation of overexpression of ATRIP as an example. ATRIP is the 
ATR (ataxia telangiectasia and Rad3 related)­interacting protein, it is in a 
HA­Flag–tagged expression construct, and it is one of the ORFs in our li­
brary. To this aim, we first transfected the HA­Flag ATRIP plasmid into the 
cells. After paraformaldehyde fixation, the cells were subjected to immuno­
fluorescence staining using anti­Flag (only to indicate which cells express 
exogenous HA­Flag ATRIP) and using anti­ATRIP antibodies (can stain cells 
expressing HA­Flag–tagged ATRIP or untransfected cells only expressing 
endogenous ATRIP). After that, we measured fluorescence intensity from the 
area of the transfected cells expressing HA­Flag–tagged ATRIP or untrans­
fected cells only expressing endogenous ATRIP (both from the anti­ATRIP 
channel). Level of overexpression = (Fluorescence intensity transfected cell/
Area  Fluorescence intensity background/Area)/(Fluorescence intensity 
untransfected cell/Area  Fluorescence intensity background/Area). We 
estimated the level of overexpression for the remaining 35 ORFs using the 
same strategy as we showed for ATRIP in Fig. S1.
DNA constructs
DNA constructs used in this study were obtained from the human ORFeome 
v5.1 collection as the pDONR223 entry clone and subsequently trans­
ferred to a Gateway­compatible destination vector for protein expression. 
The SFB tag is a triple­epitope tag (S protein, Flag, and streptavidin bind­
ing peptide), which allows efficient detection and purification of exogenously 
expressed proteins. Internal deletion mutants or point mutations of TOE1 
were constructed by using the site­directed mutagenesis kit (QuikChange; 
Agilent Technologies) and verified by sequencing.
Antibodies
Mouse monoclonal anti–­tubulin, anti–­actin, anti­HA, anti­Flag (M2), 
and anti–sc­35 antibodies were obtained from Sigma­Aldrich; rabbit poly­
clonal anti­coilin (H­300), anti­PML (H­238); mouse monoclonal anti­sam68 
(7–1), anti–Sm­D1 (A­9), and anti­Myc (9E10) antibodies were obtained 
from Santa Cruz Biotechnology, Inc.; mouse monoclonal anti­SMN, anti­
coilin, and anti­p54nrb antibodies were obtained from BD; rabbit poly­
clonal anti­TOE1 and anti­DKC1 antibodies were purchased from Bethyl 
Laboratories, Inc.; rabbit polyclonal anti­FBL, SFRS1, and SFRS3 antibodies 
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RNA immunofluorescence FISH
FISH was performed as described previously (Sasaki et al., 2009). In brief, 
HeLa cells were transduced with mock or shRNA against various para­
speckle proteins and selected with puromycin for 2 d. Then, cells on the 
coverslips were fixed with 4% paraformaldehyde in PBS at room tempera­
ture for 15 min. After dehydration by 70, 95, and 100% ethanol for 5 min 
each, the coverslips were incubated with prehybridization buffer (2× SSC, 
Denhardt’s solution, 50% formamide, 10 mM EDTA, 100 µg/ml Esche-
richia coli tRNA, and 0.01% Tween 20) at 55°C for 2 h. RNA probes 
against NEAT1 noncoding RNA were prepared with use of a FITC RNA la­
beling kit (Roche). Prehybridized coverslips were incubated with hybridiza­
tion buffer (5% dextran sulfate in the prehybridization buffer containing the 
FITC­labeled RNA probe) at 55°C for 16–18 h and sealed with rubber 
cement. The plasmid encoding the Neat1 RNA probe was obtained from 
T. Hirose (Biomedicinal Information Research Center, National Institute of 
Advanced Industrial Science and Technology, Koto, Tokyo, Japan). After 
probe incubation, the coverslips were washed twice with wash buffer A 
(2× SSC, 50% formamide, and 0.01% Tween 20) at 55°C for 20 min and 
washed once with wash buffer B (2× SSC and 0.01% Tween 20) at 55°C 
for 20 min and twice with wash buffer C (0.1× SSC and 0.01% Tween 20) 
at 55°C for 20 min. To detect the probe, the coverslips were first blocked 
with blocking buffer (1% blocking reagent [Roche] in TBST [TBS with 
Tween 20]) at room temperature for 1 h and then incubated with anti­FITC 
antibodies against the RNA probes and/or antibodies against paraspeckle 
proteins diluted with blocking buffer for 1 h. The coverslips were then 
washed three times in TBST for 15 min, incubated with the secondary anti­
bodies at room temperature for 1 h, stained with DAPI to visualize the 
DNA, and mounted onto the glass slides.
qRT-PCR
Total RNAs from siRNA­ or shRNA­treated cells were extracted by TRIZOL 
(Invitrogen). Next, 1 µg/ml RNA was reverse transcribed with use of 
Moloney murine leukemia virus Taq RT­PCR kit (ProtoScript; New England 
Biolabs, Inc.). cDNAs were subjected to real­time PCR with use of Power 
SYBR Green PCR Master Mix (Applied Biosystems) according to the man­
ufacturer’s protocol. The primer sequences are used as follows: NEAT1 
forward primer 1, 5­CAATTACTGTCGTTGGGATTTAGAGTG­3; NEAT1 re­
verse primer 1, 5­TTCTTACCATACAGAGCAACATACCAG­3; NEAT1 for­
ward primer 2, 5­TGTGTGTGTAAAAGAGAGAAGTTGTGG­3; NEAT1 
reverse primer 2, 5­AGAGGCTCAGAGAGGACTGTAACCTG­3; GAPDH 
forward primer, 5­ACAACTTTGGTATCGTGGAAGG­3; GAPDH reverse 
primer, 5­GCCATCACGCCACAGTTTC­3; DPP8 forward, 5­TCTATTA­
CCTTGCCATGTCTGGTG­3; DPP8 reverse, 5­AATACATTCCATAGTCCA­
GTGTTG­3; NOSIP forward, 5­CTGGAGAAGCCGTCCCGCACGGTG­3; 
NOSIP reverse, 5­CACGGCACACACGTAGCGCTCGCT­3; DDX20 for­
ward, 5­TTAAGTACCCAGATTTTGATCTTG­3; and DDX20 reverse, 5­AAG­
TCTGGTTTTGTCTTGTGATAA­3.
Online supplemental material
Fig. S1 examines the level of overexpression of ORFeome library in our 
study. Fig. S2 shows a bioinformatics analysis of the nuclear foci pro­
teome. Fig. S3 shows a proteomic analysis of various nuclear subcompart­
ments. Fig. S4 shows that TOE1 is required for endogenous mRNA splicing. 
Fig. S5 shows the validation of identified paraspeckle proteins. Table S1 is 
an inventory of nuclear foci proteome with GO analysis. Table S2 shows a 
comparison with NOPdb. Table S3 shows a comparison with different da­
tasets. Table S4 shows the classification of unknown nuclear foci. Table S5 
shows the InterProScan analysis. Table S6 shows the top hit protein motif 
among various nuclear bodies. Table S7 is a list of interacting proteins 
from mass spectrometry analysis. Online supplemental material is avail­
able at http://www.jcb.org/cgi/content/full/jcb.201303145/DC1. Addi­
tional data are available in the JCB DataViewer at http://dx.doi.org/10 
.1083/jcb.201303145.dv.
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Immunofluorescence staining
Cells grown on coverslips were fixed either in methanol (20°C for 10 min) 
or in 4% paraformaldehyde in PBS at room temperature for 15 min. After 
fixation, cells were subjected to immunostaining using the same protocol 
for the large­scale screening. Images were captured with use of a fluor­
escence microscope (Eclipse E800; Nikon) equipped with a Plan Fluor 
40× oil objective lens (NA 1.30; Nikon) and a camera (SPOT; Diagnostic 
Instruments, Inc.). Images were captured using NIS­Elements basic research 
imaging software (Nikon) and analyzed using Photoshop CS4 (Adobe).
Tandem affinity purification of SFB-tagged protein complexes
293T cells were transfected with plasmids encoding the protein of interest. 
Cell lines stably expressing the protein of interest were selected in a cell 
culture medium containing 2 mg/ml puromycin and were verified by im­
munostaining and Western blotting. For tandem affinity purification, 293T 
cells were lysed in NETN (100 mM NaCl, 20 mM Tris­Cl, pH 8.0, 1 mM 
EDTA, and 0.5% [vol/vol] NP­40) buffer containing protease inhibitors for 
20 min at 4°C. Crude lysates were subjected to centrifugation at 14,000 rpm 
for 30 min. Supernatants were then incubated with streptavidin­conjugated 
beads (GE Healthcare) for 4 h at 4°C. The beads were washed three times 
with NETN buffer, and bounded proteins were eluted with NETN buffer con­
taining 2 mg/ml biotin (Sigma­Aldrich) for 1 h twice at 4°C. The elutes 
were incubated with S­protein beads (EMD Millipore) overnight at 4°C. 
The beads were eluted with SDS sample buffer and subjected to SDS­PAGE. 
Protein bands were excised and subjected to mass spectrometry analysis.
Mass spectrometry data analysis
Mass spectrometry analysis was performed by the Taplin Mass Spectrometry 
Facility at Harvard Medical School. General contaminant proteins, such as 
heat shock proteins and ribosomal proteins, were discarded after compari­
son with results from control purifications. The protein of interact was manually 
sorted based on a literature search by the particular complex they form and/ 
or any common domain they contain. After that, the protein–protein inter­
action networks were drawn and presented as cartoons in Fig. 3 and Fig. 4.
Bioinformatics analysis
GO analysis was performed with the UniProt­GO Annotation Database. 
In brief, symbols of the proteins were entered into the database. The anno­
tated GO components, GO process, and GO function for each input 
would be displayed and then manually recorded in Excel (Microsoft). 
Finally, the data in the spreadsheet were sorted, and top hits of annotated 
GO process and GO function among the spreadsheet were presented as 
bar graphs. Also, a pie chart was used to show the percentage of proteins 
in the lists annotated with the GO component nucleus. To analyze the 
protein motif belonging to the listed proteins, we used the InterProScan tool 
at the European Bioinformatics Institute website (Protein Function Analysis), 
and this tool consists of a cocktail of databases for protein motif predic­
tion. The protein sequence was first entered into InterProScan. Next, the 
motifs found for each input were recorded. Top hits of motifs were shown 
as a bar graph. Nucleolar proteins found in this screen were compared 
with those deposited in the NOPdb (Nucleolar Proteome Database). Any 
overlapping nucleolar protein was marked, and the overall results were 
shown in a bar graph.
Splicing reporter assay
72 h after siRNA transfection, the pSI splicing reporter (obtained from 
M.D. Hebert, The University of Mississippi Medical Center, Jackson, MS) 
was introduced into the cells by Lipofectamine 2000. 24 h later, cells were 
harvested, and total RNAs were extracted by TRIZOL (Invitrogen). The re­
sultant RNAs were subsequently digested by DNase I (Sigma­Aldrich) fol­
lowed by RT­PCR reaction using primer RP1. Next, primers FP1 and RP1 
were used to amplify both spliced and unspliced RNAs with different prod­
uct sizes. Primers FP1 and RP2 were used to only amplify the intron­contain­
ing fragment present in unspliced RNAs. Primers FP2 and RP1 were used 
to amplify a common fragment in both spliced and unspliced RNAs as the 
internal loading control among different samples. The PCR products were 
run on 2% DNA agarose gel. The resulting gel image was exported as 
TIFF format. Quantity One software (Bio­Rad Laboratories) was used to 
quantify the intensity of gel bands. The primer sequences are as follows: 
FP1, 5­AGGCTTTTGCAAAAAGCTTGATTCTTCTGACACAACAG­3; FP2, 
5­GTGTCCACTCCCAGTTCAATTACAGCTCTTAAG­3; RP1, 5­CTCATC­
AATGTATCTTATCATGTCTGCTCGAAGCG­3; and RP2, 5­GTGGAGAG­
AAAGGCAAAGTGG­3.
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